Ten-year risk of false positive screening mammograms and clinical breast examinations

The New England Journal of Medicine
J G ElmoreS W Fletcher

Abstract

The cumulative risk of a false positive result from a breast-cancer screening test is unknown. We performed a 10-year retrospective cohort study of breast-cancer screening and diagnostic evaluations among 2400 women who were 40 to 69 years old at study entry. Mammograms or clinical breast examinations that were interpreted as indeterminate, aroused a suspicion of cancer, or prompted recommendations for additional workup in women in whom breast cancer was not diagnosed within the next year were considered to be false positive tests. A total of 9762 screening mammograms and 10,905 screening clinical breast examinations were performed, for a median of 4 mammograms and 5 clinical breast examinations per woman over the 10-year period. Of the women who were screened, 23.8 percent had at least one false positive mammogram, 13.4 percent had at least one false positive breast examination, and 31.7 percent had at least one false positive result for either test. The estimated cumulative risk of a false positive result was 49.1 percent (95 percent confidence interval, 40.3 to 64.1 percent) after 10 mammograms and 22.3 percent (95 percent confidence interval, 19.2 to 27.5 percent) after 10 clinical breast examinations. The false positive te...Continue Reading

References

Mar 1, 1992·AJR. American Journal of Roentgenology·D B Kopans
Jan 1, 1991·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·C LermanA Boyce
Apr 15, 1991·Annals of Internal Medicine·C LermanP F Engstrom
Jul 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LermanP F Engstrom
Jun 1, 1991·The British Journal of Radiology·A R Bull, M J Campbell
Dec 1, 1990·British Journal of Cancer·I T GramS E Slenker
Sep 1, 1989·Annals of Internal Medicine·D M Eddy
Nov 1, 1989·British Journal of Cancer·R EllmanP Maguire
Jun 21, 1984·The New England Journal of Medicine·G O Barnett
Aug 1, 1995·Journal of Epidemiology and Community Health·S SuttonJ Hunter
Jul 1, 1995·AJR. American Journal of Roentgenology·M N LinverR A Smith
Oct 20, 1993·Journal of the National Cancer Institute·S W FletcherS Shapiro
Jul 3, 1996·JAMA : the Journal of the American Medical Association·K KerlikowskeV Ernster

❮ Previous
Next ❯

Citations

Oct 14, 2009·Archives of Internal Medicine·Carolyn J CrandallJane A Cauley
Mar 10, 2005·JAMA : the Journal of the American Medical Association·Joann G ElmoreSuzanne W Fletcher
May 4, 2001·Cancer·B Cady, J S Michaelson
Jun 27, 2000·Statistics in Medicine·A E Gelfand, F Wang
Jun 7, 2011·European Radiology·Raquel Zubizarreta AlberdiUNKNOWN CFPR (Cumulative False Positive Risk) group(1)
Sep 9, 2011·European Radiology·Nieves AscunceUNKNOWN Cumulative False Positive Risk (CFPR) Group
Jun 15, 2006·Breast Cancer Research and Treatment·Ismail JatoiWilliam Lawrence
May 1, 2007·Breast Cancer Research and Treatment·Daniel Richard LeffAra Darzi
Jul 29, 2008·Breast Cancer Research and Treatment·Suzanne M O'NeillRobert R Edelman
Jan 17, 2009·Breast Cancer Research and Treatment·Julie M KappMichael L LeFevre
Feb 12, 2008·Breast Cancer Research and Treatment·Julie M KappTrevor D Thompson
Mar 21, 2009·Breast Cancer Research and Treatment·Linn AbrahamDiana L Miglioretti
Mar 6, 2010·Breast Cancer Research and Treatment·Julie M KappBonnie C Yankaskas
Nov 6, 2010·Breast Cancer Research and Treatment·Talya SalzNoel T Brewer
Sep 22, 2009·Cancer Causes & Control : CCC·Jennifer BrooksAnne Zeleniuch-Jacquotte
Mar 16, 2007·Journal of General Internal Medicine·Joshua J FentonJoann G Elmore
Feb 26, 2013·Journal of General Internal Medicine·Teresa Bryan, Erin Snyder
May 16, 2013·Journal of General Internal Medicine·Lauren D BlockWendy L Bennett
Jun 14, 2013·Journal of General Internal Medicine·Kim DittusUNKNOWN Breast Cancer Surveillance Consortium
Nov 26, 2010·Current Oncology Reports·Bradford R Hirsch, Gary H Lyman
Dec 11, 2003·Current Oncology Reports·Patrick J Kenney, Margarett C Ellison
Jun 7, 2005·Academic Radiology·Anna O Bilska-WolakJay A Baker
Feb 15, 2003·The American Journal of Medicine·Richard G PinckneyBenjamin Littenberg
Jul 22, 1999·American Journal of Surgery·I Jatoi
Oct 8, 1999·Disease-a-month : DM·K FordB Lum
Apr 18, 2003·Seminars in Roentgenology·Liane E Philpotts, Robert A Smith
Nov 26, 1999·The Surgical Clinics of North America·B E Sirovich, H C Sox
Nov 26, 1999·The Surgical Clinics of North America·L C HartmannF Couch
Jun 3, 2009·Annals of Internal Medicine·Diana S M BuistKatherine M Newton
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S DagarH Onyüksel
Apr 18, 2001·American Journal of Preventive Medicine·R P HarrisUNKNOWN Methods Work Group, Third US Preventive Services Task Force
Jan 5, 2002·American Journal of Preventive Medicine·Garth H RauscherJo Anne L Earp
Dec 22, 1999·American Journal of Preventive Medicine·S H Woolf, L L Dickey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.